Design, synthesis, and studies of small molecule STAT3 inhibitors
- PMID: 18006313
- DOI: 10.1016/j.bmcl.2007.10.031
Design, synthesis, and studies of small molecule STAT3 inhibitors
Abstract
A series of small molecule STAT3 inhibitors originally derived from our lead compound STA 21 were synthesized and evaluated. The most potent compound in this series, compound 1, exhibited the same anti-proliferative activities as STA 21 against prostate cancer cell lines that express constitutively active STAT3. Molecular docking showed compound 1 bound to the STAT3beta SH2 domain in a similar manner as STA 21.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous